Overview
- The five-year partnership will establish a co-innovation facility in the San Francisco Bay Area to build biology and chemistry foundation models using NVIDIA’s BioNeMo platform and next-generation Vera Rubin hardware.
- The companies are targeting a late-March opening in South San Francisco, with the exact site to be announced in March.
- Lilly scientists and NVIDIA engineers will co-locate to run a continuous learning loop that links computational modeling with automated wet-lab robotics to produce defensible “ground truth” datasets.
- The remit extends beyond discovery to clinical development, manufacturing and commercial operations, including work on digital twins and autonomous lab workflows with Thermo Fisher Scientific and Multiply Labs.
- Operational specifics remain undisclosed, including financial flows and GPU counts, though the effort builds on Lilly’s in-house AI factory powered by more than 1,000 NVIDIA Blackwell GPUs.